share_log

完美醫療:截至二零二四年三月三十一日止年度全年業績公佈

PERFECT MEDICAL: FINAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 MARCH 2024

HKEX ·  Jun 28 12:00

Summary by Futu AI

完美醫療健康管理有限公司公佈截至2024年3月31日止年度全年業績,收益微升0.3%至1,393.3百萬港元,但扣除利息、稅項及折舊前盈利下降4.4%至461.3百萬港元。公司權益持有人應佔利潤增加6.8%至315.8百萬港元,每股基本盈利維持25.1港仙。建議末期及特別股息分別為每股11.9港仙及5.4港仙,合共每股17.3港仙,年度股息為每股31.5港仙,派息比率為125.5%。本集團在香港及中國內地市場表現穩定,並在香港開設新店舖以擴大市場覆蓋面。集團維持強勁財務狀況,無外部銀行借貸,並擁有575.3百萬港元的銀行及現金結餘。董事會對未來保持謹慎樂觀,將繼續推行「雙循環」策略,結合醫療美容與非醫療美容服務,以促進集團增長及盈利能力。
完美醫療健康管理有限公司公佈截至2024年3月31日止年度全年業績,收益微升0.3%至1,393.3百萬港元,但扣除利息、稅項及折舊前盈利下降4.4%至461.3百萬港元。公司權益持有人應佔利潤增加6.8%至315.8百萬港元,每股基本盈利維持25.1港仙。建議末期及特別股息分別為每股11.9港仙及5.4港仙,合共每股17.3港仙,年度股息為每股31.5港仙,派息比率為125.5%。本集團在香港及中國內地市場表現穩定,並在香港開設新店舖以擴大市場覆蓋面。集團維持強勁財務狀況,無外部銀行借貸,並擁有575.3百萬港元的銀行及現金結餘。董事會對未來保持謹慎樂觀,將繼續推行「雙循環」策略,結合醫療美容與非醫療美容服務,以促進集團增長及盈利能力。
Perfect Medical Health Management Limited announced its full-year performance as of March 31, 2024. Revenue increased slightly by 0.3% to HKD 1393.3 million, but pre-tax profit decreased by 4.4% to HKD 461.3 million after deducting interest, taxes and depreciation. The profit attributable to equity holders of the company increased by 6.8% to HKD 315.8 million, and the basic earnings per share remained at 25.1 Hong Kong cents. The proposed final and special dividends are HKD 11.9 cents and HKD 5.4 cents per share respectively, totaling HKD 17.3 cents per share. The annual dividend per share is HKD 31.5 cents and the dividend payout ratio is 125.5%. The Group has maintained a stable performance in the Hong Kong and mainland China markets and has opened new stores in Hong Kong to expand its...Show More
Perfect Medical Health Management Limited announced its full-year performance as of March 31, 2024. Revenue increased slightly by 0.3% to HKD 1393.3 million, but pre-tax profit decreased by 4.4% to HKD 461.3 million after deducting interest, taxes and depreciation. The profit attributable to equity holders of the company increased by 6.8% to HKD 315.8 million, and the basic earnings per share remained at 25.1 Hong Kong cents. The proposed final and special dividends are HKD 11.9 cents and HKD 5.4 cents per share respectively, totaling HKD 17.3 cents per share. The annual dividend per share is HKD 31.5 cents and the dividend payout ratio is 125.5%. The Group has maintained a stable performance in the Hong Kong and mainland China markets and has opened new stores in Hong Kong to expand its market coverage. The Group maintains a strong financial position without external bank borrowing and has a bank and cash balance of HKD 575.3 million. The board of directors is cautiously optimistic about the future and will continue to implement the 'dual circulation' strategy, combining medical and non-medical beauty services to promote the Group's growth and profitability.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.